We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · September 28, 2020

Integration of Antiangiogenic Therapy With Cisplatin and Gemcitabine Chemotherapy for Nasopharyngeal Carcinoma

Clinical Cancer Research

 

Additional Info

Clinical Cancer Research
Integration of Antiangiogenic Therapy With Cisplatin and Gemcitabine Chemotherapy in Patients With Nasopharyngeal Carcinoma
Clin. Cancer Res 2020 Aug 14;[EPub Ahead of Print], WQ Chong, CM Lim, AK Sinha, CS Tan, GHJ Chan, Y Huang, NB Kumarakulasinghe, R Sundar, AD Jeyasekharan, WS Loh, JK Tay, K Yadav, L Wang, AL Wong, LR Kong, RA Soo, JA Lau, YY Soon, RM Goh, FCH Ho, SM Chong, SC Lee, KS Loh, BC Tai, YC Lim, BC Goh

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading